Skip to Content
Merck
  • Binding of thienamycin and clavulanic acid to the penicillin-binding proteins of Escherichia coli K-12.

Binding of thienamycin and clavulanic acid to the penicillin-binding proteins of Escherichia coli K-12.

Antimicrobial agents and chemotherapy (1977-09-01)
B G Spratt, V Jobanputra, W Zimmermann
PMID334066
ABSTRACT

Thienamycin and clavulanic acid are new beta-lactam derivatives with structures markedly different from those of penicillins or cephalosporins. Both derivatives had the same general mode of action as typical beta-lactam antibiotics since they bound to precisely the same proteins as [(14)C]benzylpenicillin. Thienamycin showed high affinity for penicillin-binding proteins 1, 2, 4, 5, and 6 and a lower affinity for protein 3. Protein 2 had the highest affinity for thienamycin, and concentrations from the minimal morphological change concentration (0.1 mug/ml) up to about 0.6 mug/ml resulted in the conversion of Escherichia coli KN126 into large osmotically stable round cells. Above a concentration of 0.6 mug/ml, rapid cell lysis occurred with the release of the cell contents as spheroplasts. Clavulanic acid showed good affinity for penicillin-binding protein 2, moderate affinity for proteins 1, 4, 5, and 6, and low affinity for protein 3. Protein 2 had the highest affinity for clavulanic acid, and concentrations from the minimal morphological change concentration (30 mug/ml) up to about 50 mug/ml produced a mixture of slightly elongated, swollen, bulging, and lemon-shaped cells. Above a concentration of 50 mug/ml, rapid lysis occurred with production of spheroplasts. The properties of thienamycin and clavulanic acid were compared with those of the penicillins, cephalosporins, and amidinopenicillanic acids.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Amoxicillin trihydrate: potassium clavulanate (4:1)
Sigma-Aldrich
Potassium clavulanate: silicon dioxide (1:1)